REFERENCES
1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766-81.
2. Xue H, Zhang X, Li D, et al. Relevance of physical activities, sedentary behaviors, and genetic predisposition in body fatness: population-based study on Chinese adults. Obes Facts. 2021;14:346-56.
3. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a national toxicology program workshop review. Environ Health Perspect. 2012;120:779-89.
4. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320:C375-91.
6. Hu X, Yu C, He Y, et al. Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity. BMC Microbiol. 2024;24:119.
7. Cuinat C, Pan J, Comelli EM. Host-dependent alteration of the gut microbiota: the role of luminal microRNAs. Microbiome Res Rep. 2025;4:15.
8. Spiljar M, Merkler D, Trajkovski M. The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front Immunol. 2017;8:1353.
9. Chanda D, De D. Meta-analysis reveals obesity associated gut microbial alteration patterns and reproducible contributors of functional shift. Gut Microbes. 2024;16:2304900.
10. Sun J, Germain A, Kaglan G, et al. The visceral adipose tissue bacterial microbiota provides a signature of obesity based on inferred metagenomic functions. Int J Obes (Lond). 2023;47:1008-22.
11. Hul M, Cani PD. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat Rev Endocrinol. 2023;19:258-71.
12. Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020-32.
13. Li H, Zhang L, Li J, et al. Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota. Nat Metab. 2024;6:578-97.
14. Takeuchi T, Kubota T, Nakanishi Y, et al. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature. 2023;621:389-95.
15. Wu C, Yang F, Zhong H, et al. Obesity-enriched gut microbe degrades myo-inositol and promotes lipid absorption. Cell Host Microbe. 2024;32:1301-1314.e9.
16. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19:55-71.
17. Pedersen HK, Gudmundsdottir V, Nielsen HB, et al.; MetaHIT Consortium. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376-81.
18. Ecklu-Mensah G, Choo-Kang C, Maseng MG, et al. Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study. Nat Commun. 2023;14:5160.
19. Pinart M, Dötsch A, Schlicht K, et al. Gut microbiome composition in obese and non-obese persons: a systematic review and meta-analysis. Nutrients. 2021;14:12.
20. Sze MA, Schloss PD. Looking for a signal in the noise: revisiting obesity and the microbiome. mBio. 2016;7:e01018-16.
21. Lin Y, Xu Z, Yeoh YK, et al. Combing fecal microbial community data to identify consistent obesity-specific microbial signatures and shared metabolic pathways. iScience. 2023;26:106476.
22. Meijnikman AS, Aydin O, Prodan A, et al. Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects. J Intern Med. 2020;288:699-710.
23. Barone M, Garelli S, Rampelli S, et al. Multi-omics gut microbiome signatures in obese women: role of diet and uncontrolled eating behavior. BMC Med. 2022;20:500.
24. Louis S, Tappu RM, Damms-Machado A, Huson DH, Bischoff SC. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLoS One. 2016;11:e0149564.
25. Viglioli M, Rizzo SM, Alessandri G, et al. Investigating drug-gut microbiota interactions: reductive and hydrolytic metabolism of oral glucocorticoids by in vitro artificial gut microbiota. Int J Pharm. 2024;665:124663.
26. Milani C, Lugli GA, Fontana F, et al. METAnnotatorX2: a comprehensive tool for deep and shallow metagenomic data set analyses. mSystems. 2021;6:10.1128/msystems.00583-21.
27. Bansal P, Morgat A, Axelsen KB, et al. Rhea, the reaction knowledgebase in 2022. Nucleic Acids Res. 2022;50:D693-700.
28. The UniProt Consortium. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609-17.
29. Quevillon E, Silventoinen V, Pillai S, et al. InterProScan: protein domains identifier. Nucleic Acids Res. 2005;33:W116-20.
30. Hauser M, Steinegger M, Söding J. MMseqs software suite for fast and deep clustering and searching of large protein sequence sets. Bioinformatics. 2016;32:1323-30.
32. Mancabelli L, Milani C, De Biase R, et al. Taxonomic and metabolic development of the human gut microbiome across life stages: a worldwide metagenomic investigation. mSystems. 2024;9:e0129423.
33. Tarracchini C, Alessandri G, Fontana F, et al. Genetic strategies for sex-biased persistence of gut microbes across human life. Nat Commun. 2023;14:4220.
34. de la Cuesta-Zuluaga J, Kelley ST, Chen Y, et al. Age- and sex-dependent patterns of gut microbial diversity in human adults. mSystems. 2019:4.
35. Gacesa R, Kurilshikov A, Vich Vila A, et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature. 2022;604:732-9.
36. Palmas V, Pisanu S, Madau V, et al. Gut microbiota markers associated with obesity and overweight in Italian adults. Sci Rep. 2021;11:5532.
37. Woting A, Pfeiffer N, Loh G, Klaus S, Blaut M. Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. mBio. 2014;5:e01530-14.
38. Tett A, Pasolli E, Masetti G, Ercolini D, Segata N. Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol. 2021;19:585-99.
39. Al-Sulaiti H, Diboun I, Agha MV, et al. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. J Transl Med. 2019;17:348.
40. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association. Diagnosis and management of the metabolic syndrome: an american heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112:2735-52.
41. Li TT, Chen X, Huo D, et al.; JRI Live Cell Bank Consortium. Microbiota metabolism of intestinal amino acids impacts host nutrient homeostasis and physiology. Cell Host Microbe. 2024;32:661-675.e10.
42. Choi BH, Hyun S, Koo SH. The role of BCAA metabolism in metabolic health and disease. Exp Mol Med. 2024;56:1552-9.
43. De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65:1812-21.
44. Blanco-Míguez A, Gálvez EJC, Pasolli E, et al. Extension of the Segatella copri complex to 13 species with distinct large extrachromosomal elements and associations with host conditions. Cell Host Microbe. 2023;31:1804-1819.e9.
45. Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23:859-68.
46. Verdam FJ, Fuentes S, de Jonge C, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring). 2013;21:E607-15.
47. Zhao X, Han Q, Liu Y, Sun C, Gang X, Wang G. The relationship between branched-chain amino acid related metabolomic signature and insulin resistance: a systematic review. J Diabetes Res. 2016;2016:2794591.
48. Samms RJ, Zhang G, He W, et al. Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. Mol Metab. 2022;64:101550.
49. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-10.
50. Meng F, Guo Z, Hu Y, et al. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Brain. 2019;142:700-18.
51. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31.
52. Robia J, Hammad A. The gut microbiome and its role in obesity and metabolic disease. InterConf+. 2025:151-9.
53. Nie X, Chen J, Ma X, et al. A metagenome-wide association study of gut microbiome and visceral fat accumulation. Comput Struct Biotechnol J. 2020;18:2596-609.
54. de la Cuesta-Zuluaga J, Huus KE, Youngblut ND, Escobar JS, Ley RE. Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy. Gut Microbes. 2023;15:2246634.
55. Marcus F, Gontero B, Harrsch PB, Rittenhouse J. Amino acid sequence homology among fructose-1,6-bisphosphatases. Biochem Biophys Res Commun. 1986;135:374-81.
56. Sokaribo A, Novakovski BAA, Cotelesage J, White AP, Sanders D, Goldie H. Kinetic and structural analysis of Escherichia coli phosphoenolpyruvate carboxykinase mutants. Biochim Biophys Acta Gen Subj. 2020;1864:129517.
57. Brown EM, Clardy J, Xavier RJ. Gut microbiome lipid metabolism and its impact on host physiology. Cell Host Microbe. 2023;31:173-86.
58. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30:400-18.
59. Rhee SG, Woo HA, Kil IS, Bae SH. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem. 2012;287:4403-10.
61. Pena N, Dranow DM, Hu Y, Escamilla Y, Bullard JM. Characterization and structure determination of prolyl-tRNA synthetase from Pseudomonas aeruginosa and development as a screening platform. Protein Sci. 2019;28:727-37.
62. Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10:1775.
63. Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15:261-73.
64. Kosaka T, Tsushima Y, Shiota Y, et al. Membrane potential-requiring succinate dehydrogenase constitutes the key to propionate oxidation and is unique to syntrophic propionate-oxidizing bacteria. Microbes Environ. 2023:38.
66. Imber M, Loi VV, Reznikov S, et al. The aldehyde dehydrogenase AldA contributes to the hypochlorite defense and is redox-controlled by protein S-bacillithiolation in Staphylococcus aureus. Redox Biol. 2018;15:557-68.
67. Volodina E, Steinbüchel A. (S)-3-hydroxyacyl-CoA dehydrogenase/enoyl-CoA hydratase (FadB') from fatty acid degradation operon of Ralstonia eutropha H16. AMB Express. 2014;4:69.
68. Xia Y, Lu L, Wang L, Qiu Y, Liu X, Ge W. Multi-omics analyses reveal altered gut microbial thiamine production in obesity. Front Microbiol. 2025;16:1516393.
69. Thamm AM, Li G, Taja-Moreno M, et al. A strictly monofunctional bacterial hydroxymethylpyrimidine phosphate kinase precludes damaging errors in thiamin biosynthesis. Biochem J. 2017;474:2887-95.
70. Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24:577-95.
71. Pham NHT, Joglekar MV, Wong WKM, Nassif NT, Simpson AM, Hardikar AA. Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis. Nutr Rev. 2024;82:193-209.
72. Liu P, Wang Y, Yang G, et al. The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. Pharmacol Res. 2021;165:105420.
73. Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139:1619-25.
74. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-72.
75. Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3:207-15.
76. Companys J, Gosalbes MJ, Pla-Pagà L, et al. Gut microbiota profile and its association with clinical variables and dietary intake in overweight/obese and lean subjects: a cross-sectional study. Nutrients. 2021;13:2032.
77. Zhernakova DV, Wang D, Liu L, et al.; Lifelines Cohort Study. Host genetic regulation of human gut microbial structural variation. Nature. 2024;625:813-21.
78. Andreu-Sánchez S, Blanco-Míguez A, Wang D, et al. Global genetic diversity of human gut microbiome species is related to geographic location and host health. Cell. 2025;188:3942-3959.e9.
79. Huang KD, Müller M, Sivapornnukul P, et al. Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup. Cell Rep. 2024;43:115067.
80. Peters BA, Shapiro JA, Church TR, et al. A taxonomic signature of obesity in a large study of American adults. Sci Rep. 2018;8:9749.
81. Asnicar F, Manghi P, Fackelmann G, et al. Gut micro-organisms associated with health, nutrition and dietary interventions. Nature. 2026;650:450-8.
82. Sweatt K, Garvey WT, Martins C. Strengths and limitations of BMI in the diagnosis of obesity: what is the path forward? Curr Obes Rep. 2024;13:584-95.
83. Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221-62.
